跳至主要内容
临床试验/NCT02088372
NCT02088372终止不适用

Evaluate Clinical Performance of Vanguard Knee With E1 Bearing in Korean Patient Population

Zimmer Biomet4 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Zimmer Biomet
入组人数
200
试验地点
4
主要终点
Knee Society Score

研究概览

简要总结

Evaluate Clinical Performance of Vanguard Knee with E1 Bearing in Korean Patient Population

详细描述

E1™ Vitamin E doping of highly cross-linked polyethylene is a proposed method for insuring long-term oxidative stability of highly cross-linked ultra-high molecular weight polyethylene for use in total joint arthroplasty. In vitro research and development studies have shown that this material has improved wear performance, retention of mechanical properties, and a high resistance to oxidation due to the anti-oxidative properties of Vitamin E. Biomet Inc, has received FDA clearance to market tibial polyethylene components made of E1™ for use in the Vanguard total knee replacement system.

Vanguard Total Knee System™ The Vanguard™ Knee System was designed to incorporate features from prior designs, including: ACG, Maxim, & Ascent. The Vanguard Knee includes a streamlined design, rounded sagittal profile, and a deeper trochlear groove. The femoral component is available in Cruciate Retaining (CR), Posterior Stabilizing (PS), and Super Stabilized (SSK). Tibial Bearings are available in various levels of constraint required by the surgeon (CR, PS, AS, etc.).

For this study, ONLY Vanguard with PS Bearing will be used.

The purpose of the study is to evaluate clinical performance of Vanguard Knee with E1 Bearing in TKA in Korean patient population. The clinical performance will be evaluated based on patient outcomes, radiographic assessment and survivorship.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients will be included in this study if they received Vanguard knee with E1 Bearing per the approved indications for use for Vanguard Knee. Specifically
  • Painful and disabled knee joint resulting from osteoarthritis or traumatic arthritis where one or more compartments are involved
  • Correction of varus, valgus, or posttraumatic deformity
  • Correction or revision of unsuccessful osteotomy

排除标准

  • Exclusion Criteria for this study should comply with the stated contraindications on package inserts of Vanguard™ Knee and the E1™ Tibial Bearing. These indications are stated below:
  • Absolute contraindications include: infection, sepsis, osteomyelitis, and failure of a previous joint replacement
  • Relative contraindications include:
  • Uncooperative patient or patient with neurologic disorders who are incapable of following directions,
  • Osteoporosis
  • Metabolic disorders which may impair bone formation
  • Osteomalacia
  • Distant foci of infections which may spread to the implant site
  • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
  • Vascular insufficiency, muscular atrophy, neuromuscular disease
  • Incomplete or deficient soft tissue surrounding the knee

结局指标

主要结局

Knee Society Score

时间窗: 1 year

scoring system to rate the knee and patient's functional abilities such as walking and stair climbing before and after TKA

次要结局

  • Knee Sociey Score(6 Months)
  • Knee Society Score(5 Years)
  • Modified University of California Los Angeles (UCLA) Activity Score(5 Years)
  • KOOS(5 Years)
  • EQ5D(5 Years)
  • Radiographic Assessment(5 Years)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验